Key facts
- Notable investors include Bolboreta Innova Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Medhionine
- ·The full record, as it builds
Funding rounds
No funding rounds for Medhionine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medhionine
Provider of medical content and scientific communication services intended for translating complex biomedical information. The company provides digital content, academic writing, patient education materials, and visual storytelling, enabling healthcare and life sciences businesses to access personalized, accurate, and ethically guided medical communication.
- Sector
- Business Products and Services (B2B)
- HQ
- Ceuta, Spain
- Founded
- 2022
- Employees
- 19
- Website
- medhionine.com/
- Ownership
- Privately Held (backing)
Medhionine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medhionine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medhionine in its N-PORT filings yet. We sweep new filings monthly.